ArticleJournal of assisted reproduction and genetics2025
Lycopene improves the developmental competence of vitrified-thawed oocytes by reestablishing redox balance and modulating Rock1 expression.
Article in Journal of assisted reproduction and genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Role of Glutathione in Alleviating Chilling Injury in Bovine Blastocysts: Mitochondrial Restoration and Apoptosis Inhibition.Antioxidants (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
purposeOocyte vitrification is a critical technique for female fertility preservation; however, it is often accompanied by cryodamage that compromises subsequent embryo development. Moreover, limited research has assessed the long-term effects on offspring derived from vitrified oocytes. While antioxidants are frequently used to mitigate vitrification-induced oxidative stress and have been shown to enhance embryo development, their impact on implantation and offspring outcomes remains underexplored. Lycopene (LYC), a potent natural antioxidant, has not yet been evaluated in the context of oocyte vitrification.
methodsOocytes were collected from 4-week-old C57/BL6J female mice. Fresh oocytes served as the negative control (n = 393). Vitrified-thawed oocytes were cultured in post-warming, IVF, and embryo culture media supplemented with 0 µM (positive control, n = 479), 0.05 µM (n = 485), 0.1 µM (n = 499), or 0.2 µM (n = 461) lycopene. Blastocysts from the fresh, vitrified, and LYC-0.1µM groups were transferred into the uterine horns of 3.5-dpc pseudopregnant 8-week-old ICR female mice to assess in vivo development.
resultsSupplementation with 0.1 µM lycopene significantly improved the blastocyst formation rate in vitrified oocytes (75.56 ± 8.69% vs. 66.53 ± 6.94%, P = 0.029). Lycopene treatment elevated intracellular glutathione (GSH) levels (P < 0.001) and reduced reactive oxygen species (ROS) levels (P = 0.014). Notably, 0.1 µM lycopene modulated Rock1 expression during early embryogenesis, especially at the 4-cell stage, suggesting a potential role in developmental regulation. Despite improved preimplantation development, live birth rates following embryo transfer were similar between vitrified groups with or without lycopene, and both remained significantly lower than the fresh group (P = 0.008). None of the offspring had any apparent birth defect. No significant differences were observed among offspring in birth weight, growth trajectory, major organ morphology, gonadosomatic indices, or follicles counting among offspring.
conclusionsLycopene exerts a protective effect against vitrification-induced oxidative stress by restoring redox homeostasis within oocytes and modulating Rock1 expression during early embryo development. Importantly, lycopene treatment did not compromise offspring health, supporting its potential as a safe adjunct to improve vitrification outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.